Skip to main content
. 2013 Dec 3;3:3309. doi: 10.1038/srep03309

Table 2. Mutation frequencies of the top 25 pan-cancer candidate genes in each tumour type (percentages of discovery samples).

Gene Breast Colorectal Head & Neck Kidney clear cell Lung Adeno Lung Squamous Ovarian Melanoma Thyroid Uterus Pan-cancer Weighted pan-cancer
TP53 25.2 44.5 47.1 1.6 42.9 68.4 55.6 13.5 0.0 16.1 30.7 38.0
KRAS 0.3 44.1 0.0 0.5 30.0 0.8 0.0 1.1 2.7 21.7 15.2 13.7
PIK3CA 31.3 45.6 11.8 2.7 5.0 9.8 0.0 2.2 0.0 51.1 22.3 20.9
PTEN 2.4 35.7 2.9 2.2 1.7 7.5 0.0 6.7 0.0 57.8 15.0 11.2
VHL 0.0 14.7 0.0 41.1 0.0 0.8 0.0 1.1 0.0 1.1 7.7 4.5
FBXW7 0.3 28.7 5.9 0.5 2.9 6.8 0.0 3.4 0.0 18.3 8.7 8.4
CDH1 5.4 15.4 2.9 0.5 0.8 0.8 0.0 2.2 0.0 3.9 4.7 4.9
CDH10 0.3 9.6 16.2 1.1 17.1 17.3 0.0 14.6 0.0 11.1 8.8 10.1
SMAD4 0.0 28.7 1.5 0.0 3.3 2.3 0.0 0.0 0.0 2.2 6.0 6.3
DCAF4L2 1.0 7.4 5.9 0.0 8.3 4.5 0.0 4.5 0.0 4.4 4.2 4.7
CTNNB1 0.3 19.5 1.5 0.5 3.8 1.5 0.0 3.4 0.0 30.6 8.0 6.0
OR2M3 0.0 5.9 0.0 0.0 5.8 3.8 0.0 10.1 2.7 6.7 3.7 2.9
FAM47A 0.7 4.8 2.9 0.5 9.2 7.5 0.0 14.6 1.4 6.1 4.8 4.4
FAM5C 0.7 8.8 5.9 3.2 11.7 12.0 3.7 21.3 0.0 5.0 7.0 6.8
PIK3R1 0.7 9.6 1.5 0.5 1.3 1.5 0.0 4.5 0.0 38.3 6.9 4.3
ZNF676 0.0 3.3 5.9 0.5 9.2 11.3 0.0 20.2 0.0 3.3 4.8 4.9
APC 0.3 77.6 1.5 0.5 3.3 3.0 0.0 6.7 0.0 13.9 16.5 16.0
KLHL4 0.3 8.1 7.4 0.5 8.3 5.3 0.0 9.0 1.4 7.2 5.0 5.4
WBSCR17 1.4 10.3 0.0 0.5 7.5 3.8 0.0 11.2 0.0 6.1 4.9 4.2
PRDM9 0.3 8.8 4.4 0.5 12.5 6.8 0.0 16.9 4.1 9.4 6.6 6.1
TPTE 0.3 7.0 4.4 0.0 13.3 10.5 0.0 23.6 0.0 8.9 6.8 6.2
PCDH11X 0.7 7.7 5.9 2.2 15.8 15.0 3.7 7.9 2.7 7.2 7.2 7.2
MAGEC1 0.3 7.7 5.9 1.1 9.2 9.8 0.0 15.7 1.4 9.4 6.1 5.8
EGFR 0.3 15.1 4.4 0.5 10.4 2.3 0.0 6.7 0.0 2.2 5.4 5.8
FAM47C 2.0 5.9 2.9 1.1 12.5 3.8 3.7 12.4 0.0 7.2 5.5 5.1
HHS Vulnerability Disclosure